GlassScriptPhysician profile
Taylor Anne Mitchell
NPI 1730753302
$2,711.04
in general payments reported to CMS, 2019-2025
31 companies · $1,212 in 2025
The $1,212 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $167 · 2023: $513 · 2024: $711 · 2025: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,435.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $461.04 | 2023-2025 | |
| Abbvie INC. | $438.45 | 2023-2025 | |
| Novo Nordisk INC | $364.99 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $152.96 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.38 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $103.31 | 2023-2025 | Mounjaro, Zepbound, Kisunla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $97.86 | 2023-2025 | Caplyta |
| Horizon Therapeutics Plc | $90.08 | 2021 | |
| Aytu Biopharma, INC. | $72.62 | 2022 | |
| Exact Sciences Corporation | $66.74 | 2023-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $65.85 | 2021-2024 | |
| Seqirus USA INC | $64.97 | 2024-2025 | Flucelvax, Fluad |
| Inspire Medical Systems, INC. | $63.58 | 2023 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $51.07 | 2022-2024 | Trintellix |
| Lucid Diagnostics INC. | $47.03 | 2023-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $42.89 | 2025 | Prolastin-C Liquid |
| Amgen INC. | $41.52 | 2024-2025 | Krystexxa, Otezla, Repatha |
| Astellas Pharma US INC | $38.98 | 2024-2025 | Veozah |
| Ironshore Pharmaceuticals INC. | $37.82 | 2022 | |
| Aimmune Therapeutics, INC. | $37.47 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $36.89 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $36.31 | 2025 | Auvelity |
| Merck Sharp & Dohme LLC | $22.88 | 2022 | |
| Pulmonx Corporation | $22.30 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Ibsa Pharma INC. | $22.11 | 2025 | Licart, Tirosint, Flector |
| Abbott Laboratories | $20.43 | 2024 | Freestyle Libre 3 |
| Scilex Pharmaceuticals INC. | $18.70 | 2025 | |
| Xeris Pharmaceuticals, INC. | $18.60 | 2025 | Gvoke Hypopen |
| Glaxosmithkline, LLC. | $17.72 | 2025 | Bexsero, Shingrix, Arexvy |
| Idorsia Pharmaceuticals US INC | $14.46 | 2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.03 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.